-

Mevion Selected to Equip Proton Center in Southern China

original The MEVION S250i Proton Therapy System. (Photo: Business Wire)

The MEVION S250i Proton Therapy System. (Photo: Business Wire)

LITTLETON, Mass.--(BUSINESS WIRE)--Mevion Medical Systems announced today that it has been selected to install a MEVION S250i Proton Therapy System® with HYPERSCAN® Pencil Beam Scanning (PBS) in a comprehensive hospital in Southern China.

Proton therapy is a superior form of radiation therapy that can reduce the amount of unnecessary radiation exposure to surrounding healthy tissue and sensitive organs at risk. HYPERSCAN PBS improves on these benefits by using Mevion’s unique Adaptive Aperture® pMLC to enable faster and sharper delivery of therapeutic radiation to tumors while sparing healthy tissue.

The MEVION S250i Proton Therapy System's leading-edge clinical capabilities, combined with its compact, affordable design, and industry-leading ramp-up time, have changed the landscape of proton therapy. Mevion received US FDA 510(k) clearance for the system in 2017 and is actively seeking regulatory approval from the National Medical Products Administration (NMPA) in China.

“We are proud to be selected to equip a new proton center in Southern China,” said Tina Yu, Ph.D., CEO and President of Mevion Medical Systems. “It confirms Mevion’s leading position as a trusted compact proton therapy provider and marks another milestone of our growth in China.”

According to Global Cancer Observatory, there were over 4.5 million cancer cases in China in 2020. However, only 3 proton centers are currently in clinical operation in Mainland China, leaving a substantial number of patients without access to this advanced cancer-fighting technology. As the innovator of the single-room system, Mevion’s approach allows for an expedited project timeline, efficient center operation, and financial success, all of which will benefit the underserved China market.

About Mevion Medical Systems

Since 2004, Mevion Medical Systems has been the leading provider of compact proton therapy systems for cancer care. Dedicated to advancing the design and accessibility of proton therapy worldwide, Mevion was the first company to innovate this new single-room platform and continues to further the science and application of proton therapy. Mevion’s flagship product, the MEVION S250i Proton Therapy System with HYPERSCAN pencil beam scanning, is the world’s smallest proton therapy system that eliminates the obstacles of size, complexity, and cost that exists with other proton therapy systems. Mevion is headquartered in Littleton, Massachusetts, with a presence in Europe and Asia. For more information, please visit www.mevion.com.

Follow us on Twitter: @MevionMedical

Connect with us on LinkedIn: Mevion Medical Systems

Like us on Facebook: MevionMedical

Contacts

Jingyi Wang
Marketing Manager
jwang@mevion.com
978-540-1499

Industry:

Mevion Medical Systems

Release Versions
English
Hashtags
#ProtonTherapy

Contacts

Jingyi Wang
Marketing Manager
jwang@mevion.com
978-540-1499

More News From Mevion Medical Systems

Carilion Clinic and Mevion Medical Systems Announce Plans to Bring Proton Therapy to Southwest Virginia

ROANOKE, Va. & LITTLETON, Mass.--(BUSINESS WIRE)--Carilion Clinic, a leading integrated health system serving western Virginia, and Mevion Medical Systems, the global leader in compact proton therapy, today announced a partnership to bring advanced proton therapy to the new Carilion Taubman Cancer Center, now under construction in Roanoke. A Regional Milestone in Cancer Care The new Carilion Taubman Cancer Center will transform how cancer care is delivered across Southwest Virginia, bringing to...

Loma Linda University Health, Pioneer of Hospital-Based Proton Therapy, Selects Mevion FIT System to Launch Next Era of Cancer Care

LOMA LINDA, Calif. & LITTLETON, Mass.--(BUSINESS WIRE)--Loma Linda University Health (LLUH), the institution that created the world's first hospital-based Proton Therapy Treatment Center in 1990, and Mevion Medical Systems, the leading provider of compact proton therapy solutions, today announced a historic partnership to install the MEVION S250-FIT Proton Therapy System™. This milestone represents both a clinical leap forward and a symbolic return to the front lines of innovation for LLUH, lau...

Mevion Medical Systems Announces FDA Clearance for MEVION S250-FIT™ Proton Therapy System

LITTLETON, Mass.--(BUSINESS WIRE)--Mevion Medical Systems today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the MEVION S250-FIT™ Proton Beam Radiation Therapy System, marking a significant milestone in expanding access to proton therapy.  The MEVION S250-FIT is the first and only proton therapy system designed to seamlessly fit into a standard radiation therapy vault. By leveraging existing infrastructure, the MEVION S250-FIT system lowers barrier...
Back to Newsroom